von der Leyen HE - Search Results

1

Expression of inducible nitric oxide synthase in human heart failure.

Haywood GA, Tsao PS, von der Leyen HE, Mann MJ, Keeling PJ, Trindade PT, Lewis NP, Byrne CD, Rickenbacher PR, Bishopric NH, Cooke JP, McKenna WJ, Fowler MB. Haywood GA, et al. Among authors: von der leyen he. Circulation. 1996 Mar 15;93(6):1087-94. doi: 10.1161/01.cir.93.6.1087. Circulation. 1996. PMID: 8653828

2

Induction of nitric oxide synthase in the human cardiac allograft is associated with contractile dysfunction of the left ventricle.

Lewis NP, Tsao PS, Rickenbacher PR, Xue C, Johns RA, Haywood GA, von der Leyen H, Trindade PT, Cooke JP, Hunt SA, Billingham ME, Valantine HA, Fowler MB. Lewis NP, et al. Circulation. 1996 Feb 15;93(4):720-9. doi: 10.1161/01.cir.93.4.720. Circulation. 1996. PMID: 8641001

3

Gene therapy inhibiting neointimal vascular lesion: in vivo transfer of endothelial cell nitric oxide synthase gene.

von der Leyen HE, Gibbons GH, Morishita R, Lewis NP, Zhang L, Nakajima M, Kaneda Y, Cooke JP, Dzau VJ. von der Leyen HE, et al. Proc Natl Acad Sci U S A. 1995 Feb 14;92(4):1137-41. doi: 10.1073/pnas.92.4.1137. Proc Natl Acad Sci U S A. 1995. PMID: 7532305 Free PMC article.

4

Gene inhibition and gene augmentation for the treatment of vascular proliferative disorders.

von der Leyen HE, Mann MJ, Dzau VJ. von der Leyen HE, et al. Semin Interv Cardiol. 1996 Sep;1(3):209-14. Semin Interv Cardiol. 1996. PMID: 9552513 Review.

5

Cell cycle inhibition preserves endothelial function in genetically engineered rabbit vein grafts.

Mann MJ, Gibbons GH, Tsao PS, von der Leyen HE, Cooke JP, Buitrago R, Kernoff R, Dzau VJ. Mann MJ, et al. Among authors: von der leyen he. J Clin Invest. 1997 Mar 15;99(6):1295-301. doi: 10.1172/JCI119288. J Clin Invest. 1997. PMID: 9077539 Free PMC article.

6

Therapeutic potential of nitric oxide synthase gene manipulation.

von der Leyen HE, Dzau VJ. von der Leyen HE, et al. Circulation. 2001 Jun 5;103(22):2760-5. doi: 10.1161/01.cir.103.22.2760. Circulation. 2001. PMID: 11390349 No abstract available.

7

Cell cycle-dependent regulation of smooth muscle cell activation.

Braun-Dullaeus RC, Mann MJ, Sedding DG, Sherwood SW, von der Leyen HE, Dzau VJ. Braun-Dullaeus RC, et al. Among authors: von der leyen he. Arterioscler Thromb Vasc Biol. 2004 May;24(5):845-50. doi: 10.1161/01.ATV.0000125704.28058.a2. Epub 2004 Mar 11. Arterioscler Thromb Vasc Biol. 2004. PMID: 15016640

8

A pressure-mediated nonviral method for efficient arterial gene and oligonucleotide transfer.

von der Leyen HE, Braun-Dullaeus R, Mann MJ, Zhang L, Niebauer J, Dzau VJ. von der Leyen HE, et al. Hum Gene Ther. 1999 Sep 20;10(14):2355-64. doi: 10.1089/10430349950017004. Hum Gene Ther. 1999. PMID: 10515455

9

DNA transfer into vascular smooth muscle using fusigenic Sendai virus (HVJ)-liposomes.

Mann MJ, Morishita R, Gibbons GH, von der Leyen HE, Dzau VJ. Mann MJ, et al. Among authors: von der leyen he. Mol Cell Biochem. 1997 Jul;172(1-2):3-12. Mol Cell Biochem. 1997. PMID: 9278227

10

A novel role for the cyclin-dependent kinase inhibitor p27(Kip1) in angiotensin II-stimulated vascular smooth muscle cell hypertrophy.

Braun-Dullaeus RC, Mann MJ, Ziegler A, von der Leyen HE, Dzau VJ. Braun-Dullaeus RC, et al. Among authors: von der leyen he. J Clin Invest. 1999 Sep;104(6):815-23. doi: 10.1172/JCI5339. J Clin Invest. 1999. PMID: 10491417 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

62 results

Search Page

Filters